Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2155386 | 0.98 | POLB (0.49) | POLBGAAALDH1A1RECQLLMNA | |
| SCHEMBL6929250 | 0.88 | POLB (0.59) | POLBGAAALDH1A1RECQLLMNA | |
| SCHEMBL6930770 | 0.81 | LMNA (0.70) | POLBGAAALDH1A1RECQLLMNA | |
| Hydrochloric Acid SCHEMBL7463444 | 0.81 | POLB (0.46) | POLBGAAALDH1A1RECQLLMNA | |
| SCHEMBL1745361 | 0.78 | ALDH1A1 (0.66) | POLBGAAALDH1A1RECQLLMNA | |
| SCHEMBL12374731 | 0.77 | ALDH1A1 (0.50) | POLBGAAALDH1A1RECQLLMNA | |
| SCHEMBL1469845 | 0.77 | POLB (0.59) | POLBGAAALDH1A1RECQLLMNA | |
| SCHEMBL21192307 | 0.77 | POLB (0.50) | POLBGAAALDH1A1RECQLLMNA | |
| SCHEMBL17392944 | 0.77 | POLB (0.50) | POLBGAAALDH1A1RECQLLMNA | |
| SCHEMBL3274800 | 0.77 | POLB (0.50) | POLBGAAALDH1A1RECQLLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109696-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260078116-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2026-03-19 | — | — | US | disclosed |
| CN-1167698-C | New N-triazolyl methyl piperazine derivate using as neurokinin receptor antagonistic agent | ������ҩ������˾ | 2004-09-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078116-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | MYC, KRAS, MCL1 | POLB 2668/4885GAA 3755/4885ALDH1A1 3887/4885 |
| US-20260109696-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | KRAS, MYC, NRAS | POLB 906/4885GAA 3640/4885ALDH1A1 3241/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.